Archived News

2017

November 6, 2017
Eight Senators Sign Letter to CMS Secretary Verma Regarding PAMA

October 23, 2017
NILA/AAB Submit Comments on the 2018 Medicare Part B CLFS Proposed Rates

October 6, 2017
22 Organizations Sign Letter to CMS Administrator Seema Verma Urging Suspension of Proposed PAMA Cuts

September 22, 2017
NILA Issues Press Release on Proposed 2018 Medicare CLFS Rates

September 12, 2017
NILA Submits Comments Calling for Changes to PAMA Regulations

August 11, 2017
NILA Comments – Advisory Panel Meeting on Clinical Diagnostic Laboratory Tests

July 21, 2017
CMS Issues Agenda, Code List for July 31 CLFS Public Meeting

July 17, 2017
CMS Requests Feedback from Labs as Part of Physician Fee Schedule Rule

March 30, 2017
Deadline for Reporting PAMA Private Payor Data Extended to May 30, 2017

March 24, 2017
NILA Leads Lab Groups in Calling for Delay and Fix of PAMA

February 27, 2017
New Professional and General Liability Insurance

January 13, 2017
FDA Releases Discussion Paper on Oversight of LDTs

January 10, 2017
CMS Releases Guidance for Submitting Private Payor Data as Required by PAMA

2016

December 15, 2016
NILA Press Release: NILA Applauds House Freedom Caucus Recommendation on Immediate Repeal of Medicare Lab Payment Reform Rule

November 23, 2016
Final Determinations for Repricing Definitive Drug Tests

November 23, 2016
FDA Drops Guidances for LDTS  

November 9, 2016
NILA Press Release: Eighty-Eight Members of Congress Sign Bipartisan Letter to HHS Requesting Delay of PAMA

November 7, 2016
Final Bipartisan Sign-On Letter Regarding PAMA Implementation

October 5, 2016
OIG Releases Reports on Medicare Payments for Lab Tests in 2015; Update on CMS’s Progress on Changing How Medicare Pays for Lab Tests

September 12, 2016
NILA Comments on Hospital Outpatient Prospective Payment System (HOPPS)

August 24, 2016
CMS Releases HCPCS Codes to be Reported Under PAMA

August 18, 2016
PAMA Advisory Panel to Meet September 12, 2016

August 17, 2016
FDA Releases Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus

August 9, 2016
NILA Comments to Support Reconsideration for Final Payment Determinations for Toxicology Codes G0840, G0481, G0482, G0483

August 4, 2016
Medicare Advisory Panel Votes in Favor of NILA's Reconsideration Requests for Toxicology Codes G0480, G0481, G0482, G0483

July 7, 2016
FDA Releases Draft Guidances for Next Generation Sequencing-based Tests

July 6, 2016
HHS announces new actions to combat opioid epidemic

June 30, 2016
NILA Requests CMS to Allow Reconsideration of Tier 1 Codes (G0480)

June 23, 2016
Final PAMA Regulations Published in Federal Register

June 18, 2016
NILA Comments on PAMA Regulations

June 17, 2016

 

Final PAMA Regulations Released

 June 3, 2016
Announcement of the Advisory Panel on Clinical Diagnostic Laboratory Tests Meeting on July 18, 2016

April 14, 2016
NILA Requests Meeting With CMS to Discuss PAMA Regulations

March 29, 2016
Bipartisan Group of 26 House Ways & Means Committee Members, Including More Than Half of the Ways & Means Health Subcommittee, Urge CMS Not To Rush PAMA Regulations   

March 28, 2016
Authorization of Emergency Use: In Vitro Diagnostic Device for Diagnosis of Zika Virus Infection 

March 17, 2016
May 2, 2016, Workshop on LC/MS-Based Devices 

March 3, 2016
Emergency Use of In Vitro Diagnostic Tests for Detection of Zika Virus and/or Diagnosis of Zika Virus

February 1, 2016
AAB's Resource Center for Zika Virus

January 18, 2016
NILA Files Reconsideration Request for CMS’s Drug Coding/Payment Policy   

January 11, 2016
FDA Releases Draft Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus From Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products

January 7, 2016
Senators Hatch (R-UT) and Wyden (D-OR) Urge CMS to Delay PAMA Reporting System

2015

December 17, 2015
44 U.S. Representatives Sign Letter Regarding CMS’s Proposed PAMA Regulations

December 15, 2015
19 Senators Sign Letter Regarding CMS’s Proposed PAMA Regulations

December 7, 2015
NILA Comments on LCD “MolDX: Biomarkers in Cardiovascular Risk Assessment”   

November 24, 2015
NILA Comments on CLFS Proposed Payment System (PAMA Regs)   

November 24, 2015
New York Bill Vetoed Requiring NY Personnel Laws to be Applied Nationwide   

November 24, 2015
11/10/15 MLN Connects National Provider Call on Clinical Diagnostic Lab Test Payment System Proposed Rule (Transcript)

November 23, 2015
NILA Comments on New CMS Payments for Drug Tests   

November 18, 2015
CMS Issues Final Coding / Pricing For Drug Test Codes in CY 2016   

November 17, 2015
The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies

October 26, 2015
NILA Comments On 2016 Clinical Laboratory Fee Schedule (CLFS) Coding and Pricing Determination For Toxicology Testing.   

October 26, 2015
NILA and 7 Other Health Care Organizations Forward Letter To Senate and House Regarding CLIA Modernization and Oversight of LDTs   

October 26, 2015
Hearing of House Energy and Commerce Subcommittee on Health will be held on Thursday, October 29, 2015, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing is entitled “Examining the Regulation of Diagnostic Tests and Laboratory Operations" is Postponed Until November 17.   

October 8, 2015
CMS Announces PAMA Advisory Panel Meeting on October 19, 2015  

September 29, 2015
NILA Press Release on Proposed PAMA Regulations   

September 28, 2015
California Assembly Bill No. 940   

​September 25, 2015
​CY 2016 Clinical Laboratory Fee Schedule Determinations 

September 25, 2015
Proposed PAMA Regulations Released

September 10, 2015
New Medicare Policy for CV Risk Assessment Panels 

August 28, 2015
Laboratory-developed tests are not the practices of medicine (article via MLO)

August 7, 2015
CMS Announces PAMA Advisory Panel on Clinical Lab Tests

June 19, 2015
New York State Legislature Passes Bills Governing Credentials of Out-of-State Laboratories Testing Specimens from New York Residents

June 17, 2015
CMS Public Meeting on CY 2015 Updates to the Part B Clinical Laboratory Fee Schedule (CFLS)

June 1, 2015
CCLA Lawsuit Regarding Local Coverage Determinations Dismissed (via Pathology Blawg)

May 22, 2015
Palmetto GBA Policy on Next Generation Sequencing (via Palmetto GBA)

February 23, 2015
AAB and NILA Release Comments on HELP Committee Report 

February 4, 2015
AAB and NILA Release Comments on FDA's Draft Guidances on LDTs

January 5, 2015
NILA Comments on 21st Century Cures Diagnostic Tests Initiative   

 

2014

November 3, 2014
Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems

November 3, 2014
CMS Publishes Physician Fee Schedule Final Rule

September 8, 2014
NILA Comments on 2015 Medicare Physician Fee Schedule Proposed Rule   

July 11, 2014
Summary of Calendar Year 2015 Physician Fee Schedule (PFS) Proposed Rule 

July 11, 2014
OIG Report on Laboratory Billing Provides More Questions Than Answers   

June 25, 2014
Special Fraud Alert: Laboratory Payments to Referring Physicians

June 6, 2014
Amendments (Act No. 122) to Pennsylvania's Clinical Laboratory Act May Cause Problems for Pennsylvania Labs